The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Taptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container



Santen OYPA0879/003/001

Main Information

Trade NameTaptiqom 15 micrograms/ml + 5 mg/ml eye drops, solution in single-dose container
Active SubstancesTafluprost
Timolol
Dosage FormEye drops, solution in single-dose container
Licence HolderSanten OY
Licence NumberPA0879/003/001

Group Information

ATC CodeS01ED Beta blocking agents1)
S01ED51 timolol, combinations

Status

License statusAuthorised
Licence Issued28/11/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back